A natural analogue of pterostilbene, resveratrol was reported to exert its maximum effect to reduce the levels of the cancer biomarker of plasma insulin-like growth factor-1 (IGF-1) at the optimal dose of 1 g/day administered orally to healthy volunteers. The gene discussed is IGF1; the disease is cancer.